The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Annual Change in Pulmonary Function and Clinical Phenotype in Chronic Obstructive Pulmonary Disease
Abstract
RATIONALE: Although the rate of annual decline in FEV1 is one of the most important outcome measures in chronic obstructive pulmonary disease (COPD), little is known about intersubject variability based on clinical phenotypes. OBJECTIVES: To examine the intersubject variability in a 5-year observational cohort study, particularly focusing on emphysema severity. METHODS: A total of 279 eligible patients with COPD (stages I-IV: 26, 45, 24, and 5%) participated. We conducted a detailed assessment of pulmonary function and computed tomography (CT) at baseline, and performed spirometry every 6 months before and after inhalation of bronchodilator. Smoking status, exacerbation, and pharmacotherapy were carefully monitored. Emphysema severity was evaluated by CT and annual measurements of carbon monoxide transfer coefficient. MEASUREMENTS AND MAIN RESULTS: Using mixed effects model analysis, the annual decline in post-bronchodilator FEV1 was -32±24 (SD) ml/yr (n=261). We classified the subjects of less than the 25th percentile as Rapid decliners, the 25th to 75th percentile as Slow decliners, and greater than the 75th percentile as Sustainers (-63±2, -31±1, and -2±1 [SE] ml/yr). Emphysema severity, but not %FEV1, showed significant differences among the three groups. Multiple logistic regression analysis demonstrated that the Rapid decliners were independently associated with emphysema severity assessed either by CT or carbon monoxide transfer coefficient. The Sustainers displayed less emphysema and higher levels of circulating eosinophils. CONCLUSIONS: Emphysema severity is independently associated with a rapid annual decline in FEV1 in COPD. Sustainers and Rapid decliners warrant specific attention in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035 · cited 2×
“George’s Respiratory Questionnaire (26) was examined every year, and blood was sampled also every year for measurements of circulating blood cell counts, serum IgE, erythrocyte sedimentation rate, or C-reactive protein.”
BackgroundThe St George's Respiratory Questionnaire
Jones, P. W., Quirk, F. H., & Baveystock, C. M. (1991) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80166-6 · Cited by 2,683
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Standardisation of the single-breath determination of carbon monoxide uptake in the lung
MacIntyre, N., Crapo, R. O., Viegi, G., Johnson, D. C., van der Grinten, C. P. M., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034905 · Cited by 2,255
Categorical Data Analysis Using the SAS System
(1996) · Technometrics · doi:10.1080/00401706.1996.10484575 · Cited by 1,869
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Tashkin, D. P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., & Decramer, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805800 · Cited by 1,604
Anthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.1994.03520190043033 · Cited by 1,341
Nihon-Kokyuki-Gakkai (2011) · Cited by 1,301
Pathophysiology of airflow limitation in chronic obstructive pulmonary disease
Hogg, J. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16900-6 · Cited by 1,294
Characterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157 · cited 2×
“In addition to emphysema severity, there are many other phenotypes based on clinical parameters, such as spirometry, nutritional status, exercise tolerance, and exacerbation, which have recently attracted attention (17, 18).”
BackgroundChronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
Han, M. K., Agusti, A., Calverley, P. M., Celli, B. R., Criner, G., Curtis, J. L., Fabbri, L. M., Goldin, J. G., Jones, P. W., MacNee, W., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1843cc · Cited by 1,032
Müller, N. L., Staples, C. A., Miller, R. R., & Abboud, R. T. (1988) · Chest · doi:10.1378/chest.94.4.782 · Cited by 798
Celli, B. R., Thomas, N. E., Anderson, J. A., Ferguson, G. T., Jenkins, C. R., Jones, P. W., Vestbo, J., Knobil, K., Yates, J. C., & Calverley, P. M. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1869oc · Cited by 748
SCANLON, P. D., CONNETT, J. E., WALLER, L. A., ALTOSE, M. D., BAILEY, W. C., SONIA BUIST, A., & e Lung Health Study Research Group, D. P. T. F. T. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9901044 · Cited by 731
Decramer, M., Celli, B., Kesten, S., Lystig, T., Mehra, S., & Tashkin, D. P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61298-8 · Cited by 495
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.6.8520796 · Cited by 490
Association of Radiographic Emphysema and Airflow Obstruction with Lung Cancer
Wilson, D. O., Weissfeld, J. L., Balkan, A., Schragin, J. G., Fuhrman, C. R., Fisher, S. N., Wilson, J., Leader, J. K., Siegfried, J. M., Shapiro, S. D., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-435oc · Cited by 489
Buist, A. S., & Connett, J. E. (1993) · Chest · doi:10.1378/chest.103.6.1644a · Cited by 483
Predictors of Mortality in Patients with Emphysema and Severe Airflow Obstruction
Martinez, F. J., Foster, G., Curtis, J. L., Criner, G., Weinmann, G., Fishman, A., DeCamp, M. M., Benditt, J., Sciurba, F., Make, B., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1677oc · Cited by 446
COPD exacerbations {middle dot} 1: Epidemiology
Donaldson, G. C. (2006) · Thorax · doi:10.1136/thx.2005.041806 · Cited by 371
Patel, B. D., Coxson, H. O., Pillai, S. G., Agustí, A. G. N., Calverley, P. M. A., Donner, C. F., Make, B. J., Müller, N. L., Rennard, S. I., Vestbo, J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-059oc · Cited by 326
McAllister, D. A., Maclay, J. D., Mills, N. L., Mair, G., Miller, J., Anderson, D., Newby, D. E., Murchison, J. T., & MacNee, W. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1080oc · Cited by 292
CT Scan Findings of Emphysema Predict Mortality in COPD
Haruna, A., Muro, S., Nakano, Y., Ohara, T., Hoshino, Y., Ogawa, E., Hirai, T., Niimi, A., Nishimura, K., Chin, K., et al. (2010) · Chest · doi:10.1378/chest.09-2836 · Cited by 267
Makita, H., Nasuhara, Y., Nagai, K., Ito, Y., Hasegawa, M., Betsuyaku, T., Onodera, Y., Hizawa, N., Nishimura, M., & the Hokkaido COPD Cohort Study Group (2007) · Thorax · doi:10.1136/thx.2006.072777 · Cited by 246
Self-citationImpact of Exacerbations on Emphysema Progression in Chronic Obstructive Pulmonary Disease
Tanabe, N., Muro, S., Hirai, T., Oguma, T., Terada, K., Marumo, S., Kinose, D., Ogawa, E., Hoshino, Y., & Mishima, M. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1535oc · Cited by 182
DOWSON, L. J., GUEST, P. J., & STOCKLEY, R. A. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2106036 · Cited by 179
CT-quantified emphysema in male heavy smokers: association with lung function decline
Mohamed Hoesein, F. A. A., de Hoop, B., Zanen, P., Gietema, H., Kruitwagen, C. L. J. J., van Ginneken, B., Isgum, I., Mol, C., van Klaveren, R. J., Dijkstra, A. E., et al. (2011) · Thorax · doi:10.1136/thx.2010.145995 · Cited by 177
Single Breath Carbon Monoxide Diffusing Capacity (Transfer Factor): Reply
Crapo, R. O., Gardner, R. M., & Berlin, S. L. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.4.1084a · Cited by 174
Relationship Between Pulmonary Emphysema and Osteoporosis Assessed by CT in Patients With COPD
Ohara, T., Hirai, T., Muro, S., Haruna, A., Terada, K., Kinose, D., Marumo, S., Ogawa, E., Hoshino, Y., Niimi, A., et al. (2008) · Chest · doi:10.1378/chest.07-3054 · Cited by 162
Matrix Metalloproteinase-9 Promoter Polymorphism Associated with Upper Lung Dominant Emphysema
Ito, I., Nagai, S., Handa, T., Muro, S., Hirai, T., Tsukino, M., & Mishima, M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-953oc · Cited by 155
Radiographic Emphysema Predicts Low Bone Mineral Density in a Tobacco-exposed Cohort
Bon, J. M., Fuhrman, C. R., Weissfeld, J. L., Duncan, S. R., Branch, R. A., Chang, C. H., Zhang, Y., Leader, J. K., Gur, D., Greenspan, S. L., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201004-0666oc · Cited by 154
Wise, R. A. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.08.002 · Cited by 90
Prediction of the rate of decline in FEV1 in smokers using quantitative computed tomography
Yuan, R., Hogg, J. C., Pare, P. D., Sin, D. D., Wong, J. C., Nakano, Y., McWilliams, A. M., Lam, S., & Coxson, H. O. (2009) · Thorax · doi:10.1136/thx.2008.112433 · Cited by 72
Efficacy of tiotropium in COPD patients from Asia: A subgroup analysis from the UPLIFT trial
Fukuchi, Y., Fernandez, L. C., Kuo, H., Mahayiddin, A. A., Celli, B. R., Decramer, M., Kesten, S., Liu, D., & Tashkin, D. P. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.01982.x · Cited by 50
Hizawa, N., Makita, H., Nasuhara, Y., Hasegawa, M., Nagai, K., Ito, Y., Betsuyaku, T., Konno, S., Nishimura, M., & the Hokkaido COPD Cohort Study Group (2008) · European Respiratory Journal · doi:10.1183/09031936.00115307 · Cited by 31
Self-citation
Cited by
Koo, H.-K., Vasilescu, D. M., Booth, S., Hsieh, A., Katsamenis, O. L., Fishbane, N., Elliott, W. M., Kirby, M., Lackie, P., Sinclair, I., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30196-6 · Cited by 296
Coxson, H. O., Dirksen, A., Edwards, L. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. M., Celli, B., Crim, C., Duvoix, A., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70006-7 · Cited by 274
Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
Miravitlles, M., Soler-Cataluña, J. J., Calle, M., Molina, J., Almagro, P., Quintano, J. A., Riesco, J. A., Trigueros, J. A., Piñera, P., Simón, A., et al. (2012) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2012.04.001 · Cited by 257
Lung imaging in COPD and asthma
Tanabe, N., Nakagawa, H., Sakao, S., Ohno, Y., Shimizu, K., Nakamura, H., Hanaoka, M., Nakano, Y., & Hirai, T. (2024) · Respiratory Investigation · doi:10.1016/j.resinv.2024.08.014 · Cited by 21
Periodontal status and lung function decline in the community: the Hisayama study.
Takeuchi, K., Matsumoto, K., Furuta, M., Fukuyama, S., Takeshita, T., Ogata, H., Suma, S., Shibata, Y., Shimazaki, Y., Hata, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31610-3 · Cited by 20
Metadata
- Authors
- Nishimura, M., Makita, H., Nagai, K., Konno, S., Nasuhara, Y., Hasegawa, M., Shimizu, K., Betsuyaku, T., Ito, Y. M., Fuke, S., Igarashi, T., Akiyama, Y., & Ogura, S.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-01
- Volume
- 185
- Issue
- 1
- Pages
- 44-52
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2116954144
- Cited by
- 344
- References
- 36
- FWCI
- 21.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.